Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 123494
Published online Oct 15, 2026. doi: 10.4251/wjgo.123494
Published online Oct 15, 2026. doi: 10.4251/wjgo.123494
Figure 5 A transmutation road diagram from gut-lung axis study to clinical utilization.
Key stages include: Phase A: Multiple omics measurement to identify biological markers; phase B: Pre-clinical experiment examination of traditional Chinese medicine intervening measures in orthotopic models; phase C: Biological marker verification in forward-looking cohort groups; and phase D: The design of randomized controlled experiments that include lung metastasis-free survival time as the main observation endpoint. LPS: Lipopolysaccharide; F. nucleatum: Fusobacterium nucleatum; EMT: Epithelial-mesenchymal transition; Th17: T helper 17; Treg: Regulatory T; TCM: Traditional Chinese medicine; AUC: Area under the curve; ROC: Receiver operating characteristic; RCT: Randomized controlled trial; FMT: Fecal microbiota transplantation.
- Citation: Wang GL, Deng H, Wang G, Qu NN. Mechanisms of the gut-lung axis in regulating lung metastasis of colorectal cancer and advances in traditional Chinese medicine intervention. World J Gastrointest Oncol 2026; 18(10): 123494
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/123494.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123494